PMC:7796052 / 581-856 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":"tified as prospective compound in a virtual screening process. The pharmacodynamics profile of raloxifene towards bradykinin receptors is reported in the present work, showing a weak selective partial agonist profile at the B2 receptor. In view of this new profile, its possi","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"16","span":{"begin":114,"end":124},"obj":"Gene"},{"id":"17","span":{"begin":224,"end":235},"obj":"Gene"},{"id":"20","span":{"begin":95,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Gene:3827"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Gene:624"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:D020849"},{"subj":"16","pred":"source","obj":"LitCovid-PubTator"},{"subj":"17","pred":"source","obj":"LitCovid-PubTator"},{"subj":"20","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":63,"end":236},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T6","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ece893","default":true},{"id":"LitCovid-sentences","color":"#ce93ec"}]}]}}